RxDoctor Payments Data

Roger Ogden, MD

Foot and Ankle Surgery · New Orleans, LANPI 1700817673

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by ALON Medical Technology at 38.3% of the total. Reporting peaked in 2023 at $2,404 and has fallen 84.6% since, to $371 in 2025.

$4,609in general payments, 2019–2025

Across 40 payments — averaging $115.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ALON Medical Technology$2K
  • Arthrex$1K
  • Treace Medical Concepts, Inc.$496
  • Johnson & Johnson$495
  • Stryker$364
  • Sanara Medtech Inc.$200
  • plus $240 from 4 others

What the payments were for

  • Travel & lodging$1,73838%
  • Food & beverage$2,16447%
  • Education$61013%
  • Gifts$972%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,609 in reported general payments places this provider in the 60th percentile of 92 foot and ankle surgery providers in Louisiana.

See all foot and ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$102,561
Medicare patients
319
Services billed
1,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone142$882
Doxycycline Hyclate14$136
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$117

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →